Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2021 May 19;12(5):775.
doi: 10.3390/genes12050775.

A Large Family with p.Arg554His Mutation in ABCD1: Clinical Features and Genotype/Phenotype Correlation in Female Carriers

Affiliations
Clinical Trial

A Large Family with p.Arg554His Mutation in ABCD1: Clinical Features and Genotype/Phenotype Correlation in Female Carriers

Rosa Campopiano et al. Genes (Basel). .

Abstract

X-linked adrenoleukodystrophy (X-ALD, OMIM #300100) is the most common peroxisomal disorder clinically characterized by two main phenotypes: adrenomyeloneuropathy (AMN) and the cerebral demyelinating form of X-ALD (cerebral ALD). The disease is caused by defects in the gene for the adenosine triphosphate (ATP)-binding cassette protein, subfamily D (ABCD1) that encodes the peroxisomal transporter of very-long-chain fatty acids (VLCFAs). The defective function of ABCD1 protein prevents β-oxidation of VLCFAs, which thus accumulate in tissues and plasma, to represent the hallmark of the disease. As in many X-linked diseases, it has been routinely expected that female carriers are asymptomatic. Nonetheless, recent findings indicate that most ABCD1 female carriers become symptomatic, with a motor disability that typically appears between the fourth and fifth decade. In this paper, we report a large family in which affected males died during the first decade, while affected females develop, during the fourth decade, progressive lower limb weakness with spastic or ataxic-spastic gait, tetra-hyperreflexia with sensory alterations. Clinical and genetic evaluations were performed in nine subjects, eight females (five affected and three healthy) and one healthy male. All affected females were carriers of the c.1661G>A (p.Arg554His, rs201568579) mutation. This study strengthens the relevance of clinical symptoms in female carriers of ABCD1 mutations, which leads to a better understanding of the role of the genetic background and the genotype-phenotype correlation. This indicates the relevance to include ABCD1 genes in genetic panels for gait disturbance in women.

Keywords: ABCD1; X-linked adrenoleukodystrophy; diagnosis; neurogenetics; next generation sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Pedigrees of the investigated family. The genetic evaluation included nine people, eight female and one male. Of the eight females, five are affected: III:2; III:6; III:10; IV:2; and IV:4, and three are healthy: IV:8; V:1; and V:2. The affected male died within the first decade (III:4; III:8; III:13; and III:14).
Figure 2
Figure 2
Axial FLAIR MRI sequences show small and diffuse hyperintensities in white matter and nuanced periventricular hyperintensities in patients III:6 (A) and IV:2 (B).

Similar articles

Cited by

References

    1. Moser H.W., Mahmood A., Raymond G.V. X-linked adrenoleukodystrophy. Nat. Clin. Pract. Neurol. 2007;3:140–151. doi: 10.1038/ncpneuro0421. - DOI - PubMed
    1. Jangouk P., Zackowski K.M., Naidu S., Raymond G.V. Adrenoleukodystrophy in female heterozygotes: Underrecognized and undertreated. Mol. Genet. Metab. 2012;105:180–185. doi: 10.1016/j.ymgme.2011.11.001. - DOI - PubMed
    1. Engelen M., Kemp S., de Visser M., van Geel B.M., Wanders R.J., Aubourg P., Poll-The B.T. X-linked adrenoleukodystrophy (X-ALD): Clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet. J. Rare Dis. 2012;13:51. doi: 10.1186/1750-1172-7-51. - DOI - PMC - PubMed
    1. Horn M.A., Retterstøl L., Abdelnoor M., Skjeldal O.H., Tallaksen C.M. Adrenoleukodystrophy in Norway: High rate of de novo mutations and age-dependent penetrance. Pediatr. Neurol. 2013;48:212–219. doi: 10.1016/j.pediatrneurol.2012.12.007. - DOI - PubMed
    1. Engelen M., Barbier M., Dijkstra I.M., Schür R., de Bie R.M., Verhamme C., Dijkgraaf M.G., Aubourg P.A., Wanders R.J., van Geel B.M., et al. X-linked adrenoleukodystrophy in women: A cross-sectional cohort study. Brain. 2014;137:693–706. doi: 10.1093/brain/awt361. - DOI - PubMed

Publication types

Substances